The Clinical Challenge
A 47-year-old man with super-morbid obesity (body mass index [BMI] = 81 kg/m 2 ) presented to the emergency department with leg swelling and mild dyspnea. The leg swelling was long standing, but had increased over the course of 1 month to the point that ambulation had become difficult. His dyspnea was progressive over the course of 1 week and was significantly worse with exertion. He reported no associated cough, fever, chest discomfort, or pleurisy. He was a life-long nonsmoker. His initial temperature was 36.8 8 C, blood pressure was 122/75 mm Hg, heart rate 118 beats/min, respiratory rate 16 breaths/min, and oxygen saturation by pulse oximetry 75% while breathing ambient air. His mental status was fully intact during his initial examination and auscultation of his chest revealed bibasilar rales and distant breath sounds. His cardiovascular examination was limited by body habitus, but S1 and S2 were normal, without appreciable extra heart sounds. There was no appreciable jugular venous distension. His extremity examination was notable for symmetric 31 pitting edema in both legs extending to his upper thighs. Laboratory studies were: 139 mM sodium, 4.5 mM potassium, 97 mM chloride, 33 mM bicarbonate, 17 mM blood urea nitrogen, and 0.97 mM creatinine. Although no blood gas was obtained at the time or presentation, the patient's elevated serum bicarbonate suggested chronic, mild hypercapnia. His chest radiograph was extremely poor in quality, due to body habitus, and the lung fields were judged to be uninterpretable.
In response to his low oxygen saturation, supplemental oxygen was given via nasal cannula at 2 L/min. The patient's follow-up saturation was 98%. Approximately 30 minutes later, he became somnolent. An arterial blood gas revealed a pH of 7.11, arterial carbon dioxide (CO 2 ) pressure (Pa CO 2 ) of 99 mm Hg, and arterial oxygen pressure (Pa O 2 ) 159 mm Hg (Table 1 ). The patient was intubated and mechanically ventilated with a tidal volume (VT) of 450 ml, fraction of inspired oxygen 1.0, positive end-expiratory pressure 5 cm H 2 O, and respiratory rate 16 breaths/min. He was treated with furosemide in 40-to 80-mg intravenous doses given up to three times daily, which elicited an appropriate increase in urine output. Over the following 10 days, the patient had a net negative 
Clinical Reasoning
Obesity hypoventilation syndrome (OHS) is defined by the combination of obesity (BMI . 30 kg/m 2 ) and awake hypoventilation (Pa CO 2 . 45 mm Hg) in the absence of other causes of hypoventilation. The condition was originally coined Pickwickian syndrome by Burwell and colleagues in 1956 after the obese, somnolent character "Joe" in Charles Dickens' 1837 novel, The Posthumous Papers of the Pickwick Club. The recognition and diagnosis of OHS is often confounded by the presence of multiple comorbidities at the time of patients' first healthcare contact. In extremis, patients with OHS become increasingly hypercapnic, due to the inability to appropriately eliminate CO 2 . In many cases of OHS, hypoxemia is responsible for a greater proportion of ventilatory drive. As a clinician, the instinct is to treat the immediate threat, which typically means reversal of hypoxemia and diuresis. Both interventions, although necessary, may produce further problems in OHS that provide a renewed threat of danger.
The patient's initial rapid decompensation was ultimately attributed to administration of supplemental oxygen, resulting in an excessive rise in Pa O 2 that contributed to acute on chronic hypercapnia. After initiation of mechanical ventilation, the patient's Pa CO 2 , arterial pH, and mental status progressed toward normal. The rapid reduction in plasma volume after furosemide administration combined with underlying chronic bicarbonate retention exacerbated his metabolic alkalosis. The acute metabolic alkalosis superimposed upon the physiological effects of a chronic hypercapnia made it difficult to achieve acceptable levels of Pa CO 2 during spontaneous breathing trials and prolonged the patient's time on the ventilator.
The Clinical Solution
Oxygenation goals were adjusted and fraction of inspired oxygen was titrated to a target oxygen saturation of 88-92% by pulse oximetry, resulting in a Pa O 2 of 55-65 mm Hg. The failed weaning attempts were treated with acetazolamide to combat iatrogenic metabolic alkalosis. Acetazolamide, a carbonic anhydrase inhibitor that increases the elimination of bicarbonate in the proximal renal tubule, was administered in 250-mg oral doses twice daily, and reduced the patient's serum [HCO 3 2 ] from 46 to 36 mM over the course of several days (Table 1) , after which he was successfully extubated.
The Science behind the Solution
The control of breathing is complex. It requires integration of a sensory system, a central controlling system, and an effector system (Figure 1 ). During resting breathing, afferent signaling to the respiratory controller from the carotid bodies, central chemoreceptors, pulmonary receptors, and mechanoreceptors in the chest wall are integrated in the medulla, which, together with (a still poorly understood) input from an intrinsic "central pattern generator," effect a ventilatory drive in the form of cortical respiratory motor outflow. This neural stimulation acts on the effector system-the respiratory muscles-through excitation-contraction coupling, to bring about a coordinated inhalation and exhalation pattern. This control system aims to maintain normal arterial oxygen pressure (PO 2 ) and CO 2 partial pressure (PCO 2 ). A disadvantaged effector system, dysregulation of ventilatory control, and disrupted sensory systems all contribute to the pathophysiological abnormalities underlying OHS.
Obesity and Hypercapnia
Obese individuals are at a significant ventilatory disadvantage. First, total cellular CO 2 production, and therefore the requirement for CO 2 output by ventilation, can be 20-30% higher in individuals with larger body surface areas. Second, adding weight to the chest and abdomen in the form of adipose tissue reduces chest wall compliance and decreases functional residual capacity, expiratory reserve volume, and, much less commonly, vital and total lung capacities. Low operating lung volumes increase airway resistance and work of breathing, 
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and predispose to small airway closure and basal atelectasis, all of which cause an intrapulmonary shunt and contribute to ventilation/perfusion ( _ V= _ Q) mismatching. Normally, hypercapnia resulting from _ V= _ Q inequality is corrected by increased ventilatory drive that results in increased alveolar ventilation. In OHS, chronic hypoxemia and hypercapnia are the final result of increased airway resistance and chest wall stiffness, whereas the greater demand for ventilation in the obese individual increases the work of breathing and may drive chronic respiratory muscle fatigue. The resulting compensation in plasma and cerebrospinal fluid (CSF) buffering capacity blunts ventilatory responsiveness to both hypoxemia and hypercapnia and exacerbates the ventilatory control problem. Distribution of adiposity is likely more important than BMI in developing OHS, which can, in many cases, be reversed by weight loss.
Another likely contributor to OHS is leptin insensitivity. Leptin is produced by adipose tissue, and acts on the hypothalamus to suppress appetite, but also stimulates ventilation. The carotid body also expresses leptin receptors, increasing its discharge and driving ventilation when stimulated by circulating leptin. Although leptin deficiency results in reduced ventilation in animal models, obese individuals are hyperleptinemic. However, a high-fat diet and metabolic syndrome appear to be associated with blunted, leptin-dependent sensor signaling in animals and blunted, hypercapnic responsiveness in patients with OHS.
Collectively, patients with OHS are characterized by chronic abnormalities in the chemo-and mechanosensory systems delivering neural input to the ventilatory controller (Figure 1 ), which causes reduced ventilatory motor outflow. Finally, the respiratory muscles are also mechanically disadvantaged. The result is a compensated respiratory acidosis, blunted, hypoxic, hypercapnic, and leptin sensitivity, mechanical constraint, and hypoventilation.
Chemical and Neural Control of Breathing
Chemoreceptors are highly specialized cells that respond to changes in the composition of the fluid surrounding them. Chemoreceptors in humans are primarily located in the ventral medulla oblongata (central) and carotid bodies (peripheral). Central chemoreceptors respond to changes in pH and Pa CO 2 , whereas peripheral chemoreceptors respond to changes in pH, Pa CO 2 , and Pa O 2 (Figure 1) . The highly specialized hemoglobin molecule, with its ability to maintain a high saturation over a wide range of Pa O 2 (60-100 mm Hg), reduces the need to tightly regulate Pa O 2 over the normal physiologic range, and therefore, arterial pH and Pa CO 2 are the primary variables regulated by ventilation.
Central Chemoreceptors
The central chemoreceptors respond to changes in CSF pH (pH CSF ) rather than the pH of arterial blood. The blood brain barrier isolates these chemoreceptors from the systemic circulation, and is relatively, but not completely, impermeable to hydrogen ions (H Figure  3A represents normal chemoreceptor sensitivity to Pa CO 2 effecting an increase in ventilation. Above a low-threshold value, ventilation increases in linear proportion to Pa CO 2 . On the other hand, central chemoreceptors are not sensitive to Pa O 2 ( Figure 3B ). Under normal conditions, central chemoreceptors are likely responsible for about 80% of the CO 2 -induced drive to breathe.
Peripheral Chemoreceptors
Peripheral chemoreceptors are found in the carotid bodies located at the bifurcation of the common carotid arteries. Their very high blood flow relative to metabolic rate allows them to accurately detect arterial PO 2 , pH, and PCO 2 . The carotid body is unique in its sensitivity to PO 2 . Nervous output from the carotid body is significantly damped when Pa O 2 exceeds 100 mm Hg, and is almost silent above approximately 400-500 mm Hg. However, the carotid body response is extremely nonlinear, such that 
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firing increases dramatically when Pa O 2 falls below 60 mm Hg ( Figure 3D ).
It has been estimated that only about 20% of the CO 2 -induced drive to breathe is mediated by the carotid bodies. Sensitivity to hypercapnia is increased by hypoxemia and blunted by hyperoxia ( Figure 3C ). Overall, patients with normal Pa O 2 and Pa CO 2 derive little ventilatory drive from carotid body outflow. Resection of the carotid bodies results in complete loss of hypoxemic ventilatory sensitivity.
Mechanoreceptors and the Work of Breathing
The neural control of breathing is a highly complex interplay among ventilatory pattern generators, efferent outflow, and afferent sensors. Of particular relevance to OHS are type I and II tendon organ (sensing force) and muscle spindle (sensing length) mechanoreceptors in the chest wall muscles, tendons, and joints that provide information about movement of the respiratory muscles (Figure 1) . Type III/IV unmyelinated chest wall metaboreceptors also provide information about muscle metabolic strain. Excitation of primary type Ib tendon organs of the internal intercostals has an inhibitory effect on inspiratory neuronal activity in the medulla, and this may contribute to the hypoventilation of OHS. However, there is considerable (teleologically advantageous) redundancy in the sensory motor system to the chest wall, and a precise understanding of its integrated control awaits discovery.
Combined Ventilatory Drive
The combined effect of all receptor stimuli is that ventilatory drive increases linearly once Pa CO 2 exceeds 35 mm Hg ( Figure 4A ). Ventilatory drive from hypercapnia is increased with hypoxemia by reducing the threshold for increased ventilation (.30 mm Hg), causing greater ventilation for a given Pa CO 2 , and increasing the sensitivity to Pa CO 2 (steeper slope). Metabolic acidosis and metabolic alkalosis change the threshold for ventilation without significantly changing sensitivity to Pa CO 2 ( Figure 4B ). Conversely, ventilation is blunted when the work of breathing is high. This reduces the effective Pa CO 2 sensitivity due to reduced airway pressure generation for a given ventilatory motor outflow.
The Effect of Hypoxemia
Supplemental oxygen has been used to treat respiratory failure for over 100 years. More recently, oxygen therapy has been recognized as a "double-edged sword" in several disease states. OHS is typically accompanied by chronic hypoxemia, and the immediate medical response is to provide supplemental oxygen. However, hypoxemia typically augments the overall ventilatory drive in these patients by increasing peripheral chemoreceptor outflow and reducing threshold and increasing sensitivity to Pa CO 2 ( Figure 5B ). Providing supplemental O 2 , however, does just the opposite. In newly diagnosed patients with OHS, breathing 100% oxygen for 20 minutes effectively silences peripheral chemoreceptor activity and can increase Pa CO 2 by as much as 10 mm Hg. If pulmonary perfusion is unchanged, more blood flow to low-_ V= _ Q regions causes less blood flow to high-_ V= _ Q regions. This further increases the _ V= _ Q of these regions, which increases alveolar and physiologic CASE CONFERENCES dead space. This, in turn, leads to a higher PCO 2 for a given minute ventilation. For a patient already in respiratory distress, this can be devastating. In our patient, the pathologic Pa CO 2 insensitivity at the time of presentation ( Figure 5A ) was at least partially counteracted by increased ventilatory stimulus from hypoxemia ( Figure 5B ), but this stimulus was removed by increasing his Pa O 2 ( Figure 5C ). In severe states of hypoxemia, supplemental O 2 should be provided to avoid tissue hypoxia and metabolic acidosis, but providing supplemental O 2 in excess of that required to maintain an appropriate rate of oxygen delivery (88-92% hemoglobin saturation) may have the dramatic and unwanted effect of ventilatory depression.
Apart from altering chemoreceptor sensitivity, supplemental oxygen may worsen hypercapnia in two other ways. First, correcting local hypoxia in the lungs reverses pulmonary vasoconstriction in areas of low _ V= _ Q. The increased blood flow to these poorly ventilated regions adds more blood with low PO 2 and high PCO 2 to the systemic circulation. Second, oxygen decreases the affinity of hemoglobin for CO 2 (the Haldane effect), thereby increasing the PCO 2 for a given blood CO 2 content. The degree to which each of these three factors contributes to O 2 -induced hypercapnia may vary from patient to patient, depending upon the level of initial hypoxemia and intrinsic differences in ventilatory and pulmonary vascular responsiveness to changes in O 2 and CO 2 .
Diuresis, Metabolic Alkalosis and Ventilatory Suppression
In our patient, compensation for the chronic respiratory acidosis caused by hypoventilation resulted in bicarbonate retention. Substantial volume removal with a loop diuretic precipitated a metabolic alkalosis through "contraction." Urine eliminated through the kidneys contains very little HCO 3 2 . Therefore, as the extravascular volume "contracts" with a loop diuretic-mediated diuresis, it does so around a relatively constant HCO 3 2 content, and the blood [HCO 3 2 ] increases. In addition, inhibition of sodium reabsorption in the ascending limb of the renal tubule leads to increased sodium delivery in the distal tubule. This prompts potassium and hydrogen ion excretion in exchange for sodium resorption. Metabolic alkalosis affects the threshold response to Pa CO 2 so that, at a constant Pa CO 2 in a mechanically ventilated patient, the drive to breath is reduced ( Figure 5D ).
With the generation of an iatrogenic metabolic alkalosis, our patient did not increase his ventilatory drive during spontaneous breathing trials, except when Pa CO 2 was very high. Acetazolamide, a carbonic anhydrase inhibitor, was used to stimulate renal elimination of bicarbonate and, once serum [HCO 3 2 ] was reduced, a more normal ventilatory response to Pa CO 2 was restored. With the correction of other patient factors contributing to difficult weaning, our patient was extubated safely and discharged from intensive care. It should be noted that the routine use of carbonic anhydrase inhibitors as respiratory stimulants in mechanically ventilated patients is not recommended.
Conclusions
Patients with OHS commonly present to the hospital with hypoxemia, hypercapnia, and respiratory distress. Although the initial presentation is typically characterized by insensitivity to Pa CO 2 , their hospital course can be negatively affected by iatrogenic complications. These include overcorrection of hypoxemia and induction of "contraction" metabolic alkalosis by large-volume diuresis with loop diuretics. Understanding the physiologic mechanisms behind not only the underlying disease, but also the complications that can occur during treatment, is fundamental to the appropriate treatment of OHS. This includes judicious titration of supplemental oxygen and careful correction of hypervolemia by appropriate selection of diuretic agents. n CASE CONFERENCES
